Health, Fitness & Food

In this article NES.N-CH Follow your favorite stocksCREATE FREE ACCOUNT The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides new opportunities for food companies, Nestle CEO Mark Schneider told CNBC. Investors were initially concerned about the popularity of GLP-1 drugs such as Wegovy and Ozempic as it was assumed

Artificial intelligence for cancer screening has taken off. Yet most of those new programs aren’t covered by Medicare or private insurers, which creates headwinds for companies looking to boost adoption and for patients who could benefit from the new technology.   “Traditionally, for medical devices it takes up to seven years after a product that’s

Let’s say you just joined the Club, and you are trying to figure out which stocks we think are buyable right now, right here. Ideally, what I would like members to be thinking about is a companion portfolio of up to a dozen stocks to a market index fund position — something we recommend for

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT CFOTO | Future Publishing | Getty Images CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial, which may help establish it as the new standard treatment for the condition. The company’s

In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults ages 60 and above, the company’s second-ever product to enter the U.S. market.  The decision is a

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika, and I’ll be on the ground at the American

In this article LLY NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Companies are increasing access to new blockbuster weight-loss drugs for employees, but size of employer may make a big difference

In this article OR-FR Follow your favorite stocksCREATE FREE ACCOUNT L’Oreal says it is working with start-ups and research institutions to bioprint skin that can actually “feel.” L’Oreal PARIS, France — French beauty and cosmetics giant L’Oreal is working on a form of synthetically produced skin that it says will one day be able to

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market pressure : The major stock benchmarks were moving lower Wednesday, with the Dow getting the worst of it again. Adding pressure on equities, bond yields

A Walmart Health center in Pinellas Park, Florida, US, on Tuesday, April 30, 2024.  Bloomberg | Bloomberg | Getty Images Bobbi Radford showed up at the CVS MinuteClinic in Batavia, Ohio, last Thanksgiving because she had pain in her arm. “I waited an hour and then was told to go to the [emergency room].,” Radford said. Filling the staffer

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Friday said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana, to boost supply

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Wall Street was bouncing higher Friday after, as Jim Cramer put it, a “really bad day” in the prior session. Thursday’s late-day decline happened as bond yields rose on

In this article LLY NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and is at least twice as effective — is expected to expire by the decade’s end. Michael Siluk | UCG | Getty Images For Gray

Dr. Joshua Bederson places Precision Neuroscience’s electrodes onto a brain. Ashley Capoot As the lights dimmed in an operating room at The Mount Sinai Hospital in New York City, Dr. Joshua Bederson prepared to make history. Bederson, system chair for the Department of Neurosurgery at Mount Sinai Health System, is no stranger to long hours

Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon Bell | Getty Images U.S. health officials are monitoring and preparing to combat bird flu in humans, even as they stress that the risk to the general public remains low.  A strain of bird flu called H5N1 has been confirmed

In this article CVS Follow your favorite stocksCREATE FREE ACCOUNT The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on Feb. 7, 2024. Patrick T. Fallon | AFP | Getty Images Pharmacy staff at two CVS retail stores in Rhode Island voted to join a

In this article NOVO.B-DK LLY Follow your favorite stocksCREATE FREE ACCOUNT A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The rivalry between Eli Lilly and Novo Nordisk extends beyond

In this article AZN-GB BMY LLY NVS NOV.N-CH Follow your favorite stocksCREATE FREE ACCOUNT Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called targeted radiopharmaceuticals. The therapy essentially delivers radiation directly into tumors by

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched a new multiyear program to reduce costs as it works to rebound from the rapid

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Fed foils stocks : The market